ACIP Votes Against Combined Vaccine for Young Children
The Advisory Committee on Vaccination Practices (ACIP), led by Health Secretary Robert F. Kennedy Jr., decided on Thursday that it will no longer recommend the MMRV vaccine, which protects against chickenpox, measles, mumps, and rubella, for children under four years old.
The vote, which ended 8-3 with one abstention, indicated a significant change in policy regarding the vaccine. Instead, the panel recommends that young children receive vacccinations for chickenpox separately from the MMR shots.
During the meeting, some panel members expressed concerns about a potential, albeit rare, risk of fever-induced seizures linked to the MMRV vaccine. Dr. Cody Maisner, one of the committee members, voted in favor of continuing the MMRV recommendation and shared his feelings about the anxiety it can cause for parents.
Back in 2009, ACIP reviewed similar data regarding the vaccine and concluded that combining vaccines or giving them individually was acceptable; however, they encouraged separate doses as a safer option.
Interestingly, information shared in the recent meeting revealed that a large majority of parents—around 85%—chose to have their children vaccinated with separate shots already.
Confusion arose regarding follow-up votes about extending recommendations for the Vaccines for Children (VFC) program, which provides access to vaccinations. Dr. Maisner stated that opposing the vote could lead to a disparity between recommendations for children receiving vaccines through VFC and those who don’t.
Despite this, the panel upheld previous recommendations for the VFC in another vote that ended similarly, 8-3.
Additionally, ACIP postponed a decision regarding the hepatitis B vaccine for newborns whose mothers aren’t infected, with Dr. Maisner asserting the safety of that vaccine.
Vicky Pebsworth, another committee member, raised questions about the current understanding of the hepatitis B vaccine’s safety, suggesting it might be premature to conclude that it’s undoubtedly safe.
Any recommendations made by the panel will need approval from Jim O’Neill, the acting director of the CDC, before becoming final.
This breakthrough comes in light of Kennedy’s earlier decision to replace all members of ACIP this year, claiming it was necessary to restore trust in vaccine science. Kennedy has faced criticism for those actions, but he maintains that they were intended to improve public confidence.
Meanwhile, the Department of Health and Human Services declared its intent to assess the impact of insurance coverage following ACIP recommendations.
Traditionally, insurers rely on ACIP’s advice to determine which vaccines to cover without costs to patients. Recently, the American Health Insurance Plan pledged to continue covering all ACIP-recommended vaccinations until the end of 2026.
Meanwhile, accusations have been thrown at Kennedy regarding his approach to vaccine recommendations, with former CDC director Susan Monares claiming he forced prioritization of approvals regardless of underlying scientific data. She expressed her disapproval of reducing life-saving vaccines for children.
Kennedy, however, has rejected Monares’ allegations.
